Indivior Plc (INDV)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Indivior Plc Stock (INDV) Company Profile

Indivior Plc

Healthcare (1174)

804-379-1090

234 BATH ROAD, SLOUGH, BERKSHIRE

INDV's Discussions on Twitter

INDV を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
INDV Indivior Plc	13.95	1.71B	1.12B	5.00M	-383.00M	0.01
RGC Regencell Bioscience Holdings Ltd	17.40	303.95B	0	-5.87M	-767.30K	-0.45
ZTS Zoetis Inc	156.17	74.39B	9.29B	2.52B	2.28B	5.57
HLN Haleon Plc Adr	10.38	48.97B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	15.10	47.39B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	16.76	20.17B	16.54B	-1.64B	749.00M	-1.45

Indivior Plc Stock (INDV) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-01-28	開始されました	Rodman & Renshaw	Buy
2024-07-23	開始されました	Piper Sandler	Overweight
2024-04-03	開始されました	Craig Hallum	Buy
2023-07-13	開始されました	Northland Capital	Outperform

Indivior Plc (INDV) 最新ニュース

Indivior Plc (INDV) 財務データ

Indivior Plc (INDV)

Indivior Plc Stock (INDV) Company Profile

INDV を他の銘柄と比較する

Indivior Plc Stock (INDV) Upgrades & Downgrades

Indivior Plc (INDV) 最新ニュース

Indivior PLC Announces Changes in Major Holdings - TipRanks

Wirral Council v Indivior/Reckitt: Supreme Court refuses permission to appeal representative action strike out - stewartslaw.com

Indivior PLC Corrects Director Shareholding Disclosure - TipRanks

REGIndivior PLCDirector/PDMR ShareholdingCorrection - TradingView

Naloxone Market to Reflect Significant Incremental - openPR.com

Indivior Directors Increase Stake in Company Shares - TipRanks

Suboxone Market Set to Witness Growth as Opioid Dependency - openPR.com

Substance Abuse Treatment Market Size, Trends & Growth - openPR.com

Indivior PLC Announces Changes in Major Shareholdings - MSN

Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What? - Filter

INDV DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline - ACCESS Newswire

Indivior PLC (INDV) Stock Analysis: Exploring a 9.21% Potential Upside Amidst Strategic Developments - DirectorsTalk Interviews

Suboxone Market Is Booming Nationwide with New Formulations - openPR.com

Shareholders that lost money on Indivior PLC(INDV) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

Indivior PLC Announces Change in Major Shareholder Holdings - TipRanks

Levi & Korsinsky Notifies Shareholders of Indivior PLC(INDV) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Substance Abuse Treatment Market Set to Witness Digital and Personalized Care Expansion | Indivior, Alkermes - openPR.com

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference - GlobeNewswire Inc.

Indivior to delist from London Stock Exchange, maintain primary listing on Nasdaq - MSN

Indivior PLC (INDV) Stock Analysis: Evaluating the 17.71% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Indivior PLC To Contact The Firm - ACCESS Newswire

Indivior’s exit comes as no surprise - The Times

Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming DeadlineINDV - ACCESS Newswire

Indivior PLC (INDV) Stock Price Down 3.27% on Jun 2 - GuruFocus

Opioid Use Disorder Market Projected to Witness Massive GrowthIndivior PLC, Alkermes plc - openPR.com

Trending tickers: The latest investor updates on Tesla, Palantir, Sanofi, Babcock and Indivior - Yahoo

Kalkine : Indivior’s Exit from London Exchange Impacts FTSE 100 Pharmaceutical Landscape - Kalkine Media

Indivior to delist from London Stock Exchangewill stay on Nasdaq - Insider Media Ltd

Drug maker Indivior joins London Stock Exchange exodus, 2 Jun 2025 11:00 - Shares Magazine

Kalkine : Indivior’s FTSE 100 Sector Shift: Delisting from London to Focus on Nasdaq Listing - Kalkine Media

Kalkine: Indivior Exits London as FTSE 100 Firm Focuses on Nasdaq - Kalkine Media

FTSE pharma giant joins London stock market exodus - The Telegraph

Indivior (INDV) Delists from London to Focus on U.S. Market - GuruFocus

Indivior brings curtain down on turbulent 11-year run in London - Proactive financial news

Indivior drops London listing to focus on U.S. market By Investing.com - Investing.com Nigeria

Indivior To Delist From LSE To Better Align With US Focused Business - Nasdaq

Indivior to cancel secondary listing in London - Sharecast.com

Indivior Plans to Cancel London Listing After Moving Primary to US - Bloomberg.com

Drug maker Indivior to abandon London stock market for the US - Yahoo

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained - GuruFocus

kalkine: FTSE 350 firm Indivior PLC (LON:INDV) to leave London listing after Nasdaq shift - Kalkine Media

Indivior to Cancel London Stock Exchange Listing, Focuses on Nasdaq - TipRanks

Indivior to Cancel Secondary Listing on London Stock Exchange, Maintains Primary Nasdaq Listing | Indivior Stock News - paginasiete.bo

Indivior to delist from London Stock Exchange, maintain Nasdaq listing - marketscreener.com

Indivior Announces Intention to Cancel Secondary Listing on Lond - GuruFocus

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained | INDV Stock News - GuruFocus

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 1, 2024 in Indivior PLC LawsuitINDV - ACCESS Newswire

Indivior Announces Patrick Barry as Chief Commercial Officer - The Malaysian Reserve

Indivior appoints Patrick Barry as Chief Commercial Officer By Investing.com - Investing.com South Africa

Indivior Announces Patrick Barry as Chief Commercial Officer | I - GuruFocus

Indivior appoints Patrick Barry as Chief Commercial Officer - Investing.com India

Indivior Plc (INDV) 財務データ

収益

当期純利益

現金流量

EPS

INDVに似た銘柄